baber/WOPTO huggingface dataset:
Patent NZ-551679-A (NZ)
Title: An unleaded gasoline for fuelling an internlal combustion automotive engine and a method for reducing emissions thereof
Inventor: WOLF LESLIE R
IPC: C10L1/06
Filed: 2002-05-02
Abstract: An unleaded low emissions gasoline for use in an internal combustion automotive engine is disclosed, wherein said gasoline is in compliance with ASTM D4814-01a and has an unadjusted octane (R+M)/2 of from about 80 to about 85 or the equivalent adjusted octane number, which upon combustion in the internal combustion automotive engine produces emissions of at least one of total hydrocarbons, carbon monoxide and nitrogen oxides that are no greater than such emissions produced by combustion of a comparable unleaded minimum 87 octane gasoline, wherein the comparable unleaded minimum 87 octane gasoline is in compliance with ASTM D4814-01a. The disclosure also relates to an unleaded reduced emissions gasoline for use in an automotive combustion engine containing a selected quantity of an oxygenate selected from the group consisting of ethanol, methyl tertiary butyl ether, ethyl tertiary butyl ether, tertiary amyl methyl ether, and combinations thereof and having an octane (R+M)/2 of from about 80 to about 85 or the equivalent adjusted octane number which, upon combustion in the internal automotive combustion engine, produces emissions of at least one of total hydrocarbons, carbon monoxide and nitrogen oxides that are reduced by comparison to combustion of a comparable unleaded minimum 87 octane gasoline in the internal automotive combustion engine and wherein the unleaded reduced emissions gasoline is in compliance with ASTM D4814-01a. (62) Divided Out of 529174
Patent NZ-553774-A (NZ)
Title: A teatcup, and a teatcup part
Inventor: MEHINOVIC RAZA
IPC: A01J/
Filed: 2005-08-17
Abstract: A teatcup adapted to be attached to a teat of an animal to be milked is disclosed. The teatcup includes a teatcup part (1) and a connection part (2). The teatcup part is disengageably mountable to the connection part. The teatcup part includes a shell (3) and a teatcup liner (4) having an upper opening and a lower opening. The teatcup liner forms an inner space (12) for receiving the teat through the upper opening and being provided in the shell in such a way that a pulsation chamber (12) is formed between the teatcup liner and the shell. The connection part including a milk-discharging member (32) for the discharge of milk from the teatcup, and a milk channel arranged to extend between the lower opening of the inner space of the teatcup liner and the milk-discharging member when the teatcup part is mounted to the connection part. The connection part includes a pulse supplying member for the supply of a pulsating pressure to the pulsation chamber, and a pulse channel arranged to extend between the pulsation chamber and the pulse-supplying member when the teatcup part is mounted to the connection part. The pulsation chamber is accessible via an aperture through the shell, and the pulse channel connects to the aperture when the teatcup part is mounted to the connection part. A sealing element is provided at the connection between the aperture and the pulse channel.
Patent NZ-565448-A (NZ)
Title: White hair development model animal, method for establishing white hair development model animal, method for passage of white hair development model animal, method for study on white hair development, screening method for white hair development-control means, and composition for control of white hai
Inventor: KATO MASASHI
IPC: G01N33/15
Filed: 2006-02-10
Abstract: Disclosed is a non-human model animal which exhibits white hair development with a phenotype such that the colour of the hair first growing after birth is black or almost black and following aging the model animal then exhibits spontaneous white hair development, and wherein the model animal has a gene type that the activated RET gene is genetically inserted in a hetero form and the endothelin receptor B (Ednrb) gene is deficient in a hetero form, or wherein the model animal has a gene type that the activated RET gene is genetically inserted in a hetero form and the Ednrb gene is deficient in the homo form or in a hetero form and the Ednrb gene is genetically inserted in the homo form or in a hetero form under the DbH promoter. Further disclosed is a method of establishing such a non-human mammalian model animal.
Patent NZ-578390-A (NZ)
Title: Transgene expression in avians using oviduct specific promoters and SIN vectors
Inventor: HARVEY ALEX J
IPC: C12N15/06
Filed: 2007-10-29
Abstract: Disclosed is methods of producing an exogenous protein in a transgenic avian by introducing an exogenous nucleotide sequence into an avian to create a transgenic avian, wherein said exogenous nucleotide sequence comprises a nucleic acid sequence encoding the exogenous protein operably linked to a promoter contained in a self-inactivating (SIN) vector derived from a retrovirus. The exogenous nucleotide sequence is integrated into the genome of the avian such that the exogenous protein is expressed in an oviduct cell of the avian, secreted into lumen of the oviduct and-deposited in a hard shell egg laid by the avian. The exogenous protein is then isolated from the egg white.
Patent NZ-578513-A (NZ)
Title: In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders
Inventor: SCHILLING STEPHAN
IPC: C12N15/85
Filed: 2008-01-18
Abstract: Disclosed is a transgenic non-human animal comprising cells containing a DNA transgene encoding Qpct or an isoenzyme of Qpct, which overexpresses Qpct or an isoenzyme of Qpct. Also disclosed is an in vivo method for screening for biologically active agents that inhibit or promote Qpct production and a transgenic mouse comprising a transgenic nucleotide sequence encoding Qpct operably linked to a promoter, integrated into the genome of the mouse, wherein the mouse demonstrates a phenotype that can be reversed or ameliorated with a Qpct inhibitor.
Patent NZ-578928-A (NZ)
Title: Methods to increase mobility of hematopoietic stem cells by use of a lipopeptide compound and treatment of associated diseases
Inventor: SHAKHOV ALEXANDER
IPC: A61K38/08
Filed: 2008-01-09
Abstract: Discloses the use of use of a composition comprising a lipopeptide in the manufacture of a medicament for treating a disease or disorder responsive to increasing the mobility of hematopoietic stem cells in a mammal in need thereof, wherein the lipopeptide is a compound of the formula depicted in the figure where R1 represents H or  CO-R4, R2, R3 and R4 independently are H or optionally substituted C8-C16 aliphatic; X is a peptide selected from the group consisting of SEQ ID NOs: 8, 16-18, 20, and 21; and Z is S or CH2. The medicament may be formulated for administration in combination with a radiopeptide. The composition has a therapeutic application in the treatment of neoplastic disorders.
Patent NZ-581255-A (NZ)
Title: A connector for a blind control mechanism associated with two co-axial shafts
Inventor: LICCIARDI DI STEFANO CARMELO JOSEPH
IPC: E06B9/44
Filed: 2008-05-22
Abstract: A connector (122) for a blind control mechanism, the mechanism including: i) a cylinder rotatable relative to two or more different shafts; ii) drive means connected to the cylinder and being operable to rotate the cylinder in either a blind extending direction or a blind direction; and iii) at least two biasing means (108, 110) connected to the cylinder, each biasing means being responsive to rotation of the cylinder in a blind extending direction to store energy and being responsive to rotation of the cylinder in a blind retracting direction to release stored energy and thereby apply a turning force to the cylinder, the turning force acting in the blind retracting direction. The connector has a body (116) for coupling an end portion of one of the biasing means to one of the shaft portions, and for coupling respective end portions of two adjacent the shafts together.
Patent NZ-598922-A (NZ)
Title: Gastric retentive pharmaceutical compositions for immediate and extended release of acetaminophen
Inventor: HOU SUI YUEN EDDIE
IPC: A61K9/20
Filed: 2010-08-31
Abstract: 598922 Gastric retentive dosage forms for extended release of acetaminophen or for both immediate and extended release of acetaminophen are described. The dosage forms allow effective pain relief upon once- or twice-daily dosing. Treatment using the dosage forms and methods of making the dosage forms are also described. The dosage forms comprise a extended release (ER) layer comprising a first dose of acetaminophen dispersed in a polymeric matrix (polyether is exemplified) wherein the polymeric matrix is comprised of at least one hydrophilic polymer having a molecular weight of 900,000 Daltons, which swells upon imbibition of fluid to a size sufficient to promote gastric retention, and wherein the first dose of acetaminophen is released over a time period of about 8 to 9 hours in vitro.
Patent NZ-600334-A (NZ)
Title: Process for the preparation of gadobenate dimeglumine complex in a solid form
Inventor: MOROSINI PIER FRANCESCO
IPC: C07C229/22
Filed: 2010-11-23
Abstract: Disclosed is a process for the preparation of gadobenate dimeglumine complex in a solid form. In particular, said solid form is conveniently obtained by spray-drying a corresponding liquid suspension at a given temperature and concentration. The method is particularly advantageous for the industrial scale as the solid form may be obtained by employing water as a solvent, which is a non-toxic solvent, easy to handle and basically not requiring troublesome health or safety precautions.
Patent NZ-601161-A (NZ)
Title: A programmable cylinder lock having a high number of combinations
Inventor: LORETI ALBERTO
IPC: E05B27/10
Filed: 2010-11-15
Abstract: 601161 A programmable cylinder lock of the type comprising a stator and a cylindrical rotor 2, mounted inside the stator for rotation around its own axis and having a keyhole for insertion of a key 3, and comprising inside rotor a number of key followers 4 movable along their own longitudinal and transversal directions, intended to cooperate with a key 3 inserted into the keyhole of rotor 2, and a number of locking pins 6 movable along their own longitudinal direction, the key followers 4 and locking pins 6 forming together a number of pairs and having toothings intended to cooperate in order to define the lock codification, the rotor 2 including a stop bar 9 cooperating with a longitudinal groove 10 of stator and having projections susceptible of cooperating with notches of the locking pins 6 in order to immobilize the locking pins 6 when the stop bar 9 engages the locking pins 6, and comprising a change bar 11 which is slidingly coupled with the key followers 4 in order to normally keeping the key followers 4 engaged with the locking pins 6 and to disengage the key followers 4 from the locking pins 6 when the change bar 11 provides a lock programming position, characterized in that one of the members 4, 6 which compose a pair is provided with two parallel and adjacent toothings 7a, 7b, each toothing 7a, 7b having its pitch phase displaced with respect to the pitch phase of the other toothing 7b, 7a, and in that at least one of the members 4, 6, which compose the pair has a limited mobility along the direction of the axis of rotor 2.
Patent NZ-606970-A (NZ)
Title: A method of treating attention deficit hyperactivity disorder
Inventor: EPSHTEIN OLEG ILIICH
IPC: C07K16/40
Filed: 2011-07-15
Abstract: Disclosed is the use of: a) a homeopathic activated-potentiated form of an antibody to brain-specific protein S-100; and b) a homeopathic activated-potentiated form of antibodies to endothelial NO synthase in the manufacture of a medicament for the treatment of attention deficit hyperactivity disorder.
Patent NZ-610137-A (NZ)
Title: Closure for a container
Inventor: DREYER LINO
IPC: B65D51/16
Filed: 2011-12-07
Abstract: 610137 A self-venting closure for a container is disclosed. It is particularly useful for containers with pressurized fluids such as carbonated beverages. The closure or cap has a circular base (20), a skirt (30) extending from the periphery thereof, an outer seal (60) and a plug seal (50) in the form of an annulus. At least one rib (80) lying on the surface of the base (20) in a substantially radial direction and in contact with the radially inner surface of the plug seal (50) at one end. As pressure builds the base is distended causing movement. The rib transfers any movement of the base (20), relative to the skirt (30), to the plug seal (50). The plug seal (50) is pulled radially inward which allows venting of excess pressure within the container. The outer seal (60) of the closure comprises at least one deformation portion (65) which interrupts partially the sealing effect of the outer seal (60) in case overpressure occurs.
Patent NZ-617756-A (NZ)
Title: Compositions and methods for inhibiting gene expression of hepatitis b virus
Inventor: CHIN DANIEL
IPC: C12N15/113
Filed: 2012-06-28
Abstract: Disclosed is a double-stranded ribonucleic acid molecule capable of inhibiting the expression of a Hepatitis B Virus gene in vitro by at least 80% wherein the double-stranded ribonucleic acid molecule comprises a sense strand comprising in order nucleotides 1- 19 of SEQ ID NOs: 2, 3 or 6 and an antisense strand at least partially complementary to the sense strand and wherein the sequence is less than 30 nucleotides in length; wherein the sequences are as defined in the specification.
Patent NZ-618903-A (NZ)
Title: Dry sprinklers with multiple coupling arrangements
Inventor: RINGER YORAM
IPC: A62C35/68
Filed: 2012-06-28
Abstract: A dry sprinkler (10) for a fire protection system having multiple alternative coupling arrangements for connection to the fluid supply piping of the system. The sprinkler including an inlet fitting (20) having a head portion having an external thread (24), and a body portion including an external groove (26). The system includes alternate threaded and grooved coupling arrangements for connection to a fluid supply pipe.
Patent NZ-620864-A (NZ)
Title: Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
Inventor: NAGEL NORBERT
IPC: C07D401/12
Filed: 2012-06-27
Abstract: Disclosed herein are crystalline solvates of 6-(piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride, processes for their preparation and the use thereof in the manufacture of medicaments for the treatment of conditions selected from the group consisting of hypertension, pulmonary hypertension, ocular hypertension, retinopathy, glaucoma, peripheral circulatory disorder, peripheral occlusive arterial disease (PAOD), coronary heart disease, angina pectoris, heart hypertrophy, heart failure, ischemic diseases, end organ damage, fibroid lung, fibroid liver, liver failure, nephropathy, renal failure, fibroid kidney, renal glomerulosclerosis, organ hypertrophy, asthma, chronic obstructive pulmonary disease (COPD), adult respiratory distress syndrome, thrombotic disorders, stroke, cerebral vasospasm, cerebral ischemia, pain, neuronal degeneration, spinal cord injury, Alzheimer’s disease, premature birth, erectile dysfunction, endocrine dysfunctions, arteriosclerosis, prostatic hypertrophy, diabetes and complications of diabetes, metabolic syndrome, blood vessel restenosis, atherosclerosis, inflammation, autoimmune diseases, osteopathy, infection of digestive tracts with bacteria, sepsis or cancer development and progression.
Patent NZ-623901-A (NZ)
Title: Immunoconjugate formulations
Inventor: ZHANG WEI
IPC: C07K16/46
Filed: 2006-08-02
Abstract: Disclosed is an immunoconjugate formulation that is substantially free of particles, the immunoconjugate formulation comprising: an immunoconjugate and one or more excipients selected from the group consisting of: sucrose, polysorbate 20, polysorbate 80, cyclodextrin, dextrose, glycerol, polyethylene glycol, mannitol, sodium chloride, and an amino acid, wherein the formulation is a buffered aqueous solution having a pH of 4.5 to 7.6. The present invention also provides an immunoconjugate formulation that is substantially free of aggregates, the immunoconjugate formulation comprising: an immunoconjugate, sucrose, a polysorbate and a buffering agent, wherein the formulation is a buffered aqueous solution having a pH of 4.5 to 7.6. In one embodiment the immunoconjugate comprises an antibody covalently linked to a maytansinoid.
Patent NZ-624936-A (NZ)
Title: Confectionery composition comprising a fat system
Inventor: BALL BILLIE
IPC: A23G3/52
Filed: 2013-01-15
Abstract: Provided is a confectionery composition comprising a fat system, the composition comprising an edible shell having a filling therein and the fat system being present in the filling. The filling has a solid fat content (SFC) of 35 to 65 wt% at 0°C, 5 to 20 wt% at 20°C, and 1 to 8% at 30°C. The filling is soft at low temperature for palatability, but it does not melt at ambient temperatures so it does not need refrigeration/freezing for storage or transport.
Patent NZ-713665-A (NZ)
Title: New somatostatin receptor subtype 4 (sstr4) agonists
Inventor: DOODS HENRI
IPC: C07D209/52
Filed: 2014-05-15
Abstract: The invention relates to 3-aza-bicyclo[3.1.0]hexane-6-carboxylic acid amide derivatives of general formula (I), which are agonists of somatostatin receptor subtype 4 (SSTR4), useful for preventing or treating medical disorders related to SSTR4. In addition, the invention relates to processes for preparing pharmaceutical compositions as well as processes for manufacture of the compounds according to the invention.
Patent NZ-719729-A (NZ)
Title: Inhibitors of influenza viruses replication
Inventor: ASMAL MOHAMMED
IPC: A61P31/16
Filed: 2014-11-12
Abstract: Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1)·1/2Η20, Form F of HCl salt of Compound (1)·3Η20, Form D of HCl salt of Compound (1), Form A of Compound (1), and Form A of tosylate salt of Compound (1). Such polymorphic forms are employed for treating influenza, inhibiting the replication of influenza viruses, or reducing the amount of influenza viruses in a biological sample or in a subject.
Patent NZ-723185-A (NZ)
Title: Electronically monitored and portable point-of-care hand hygiene dispenser having security features
Inventor: HINES JOHN
IPC: G08B21/24
Filed: 2015-01-14
Abstract: A secure point-of-care dispenser is described. The dispenser comprises, among other features, at least one main body interlock comprises a lock spring and a locking arm including a rear portion configured to engage the lock spring, a pivot portion configured to allow rotation of the locking arm about a pivot axis, a hook element formed proximate a front portion of the arm, and a vertical opening extending at least partially through the locking arm proximate the hook element. A key barrel extends from the pivot portion of the locking arm toward the exterior of the main body where it may accept a key. The invention provides a more secure mechanism for locking a point of care dispenser.
Patent NZ-730511-A (NZ)
Title: Methods and compositions for inducing protective immunity against filovirus infection
Inventor: STEIGERWALD ROBIN
IPC: A61K39/12
Filed: 2015-09-03
Abstract: The present invention provides compositions, vaccines and methods for inducing protective immunity against filovirus infection, particularly protective immunity against infection of one or more subtypes of Ebola viruses and Marburg virus. In particular, A vaccine combination that has a first composition that comprises an adenoviral-based vaccine encoding glycoantigenic proteins of at least one Ebolavirus subtype and a second composition that comprises an MVA-based vaccine encoding glycoantigenic proteins of at least one Ebolavirus and another filovirus subtype, administered in a prime-boost regimen and methods thereof to enhance immune response against filoviruses.
Patent NZ-759909-A (NZ)
Title: Optical cleaning cartridge
Inventor: KUMAR ASHISH
IPC: G02B27/00
Filed: 2019-04-02
Abstract: There is disclosed an apparatus for cleaning an optical component in an analysis unit that is configured to analyse, using the optical component, samples that are located in a removable cartridge during analysis. The apparatus may include a cleaning cartridge frame that is configured to be receivable by and supported by a cartridge receiver of the analysis unit that is configured to receive and support the removable cartridge. The apparatus may also include one or more optical cleaning assemblies, each optical cleaning assembly including an absorbent cleaning pad and a compliant support structure that is proud of a surface of the cleaning cartridge frame and interposed between the cleaning cartridge frame and at least a portion of the cleaning pad.
Patent NZ-768908-A (NZ)
Title: Pv module mounting assembly with clamp/standoff arrangement
Inventor: LEITCH PAUL BENJAMIN
IPC: F24S25/615
Filed: 2019-03-21
Abstract: A mounting assembly for use in mid-grab and/or edge-grab applications may include a clamp secured to a stanchion by a clamping fastener. The mounting assembly may also include a mounting plate which may be secured to a mounting device by the stanchion. The mounting assembly may be used, for example, to secure photovoltaic modules (or other devices or structures) of varying heights to a roof or other building surface. The mounting assembly facilitates the installation of structures, such as a PV module, on a building surface without puncturing the building surface.
Patent NZ-770766-A (NZ)
Title: Modularized subsea seawater desalination system
Inventor: TAYEBI DAVOUD
IPC: C02F103/08
Filed: 2019-10-14
Abstract: The present invention relates to a modularized subsea desalination system that does not take up substantial land on shore and aims to utilise the hydrostatic pressure undersea to perform reverse osmosis on saline water to produce fresh water. A subsea desalination template includes subsea desalination module zones 41 and module fluid couplings 46. A desalinated water outlet is in fluid connection with the module fluid coupling 46 in the subsea desalination module zone. Subsea desalination modules 5 with reverse osmosis cartridges 23 are in fluid connection with a subsea template fluid coupling 47, a seawater inlet section and a concentrated seawater outlet section. A transport pump assembly 48 for desalinated water in a pump module 17 is in fluid connection with the subsea desalination template 1 and the desalination modules 5. A seawater circulation pump 49 is in fluid connection with a seawater side of the at least one reverse osmosis cartridge 23. A desalinated water pipeline 2 convey fluid from the desalinated water transport pump assembly 48 to a location above a sea level. Furthermore, the invention relates to a subsea desalination module 5 and a method exchanging a subsea desalination module 5 requiring service.